Don't forget the royalty and milestones payments to Brickell, they're not insignificant, plus eps multiples after usually after tax.
On the other hand 10x is much too low a multiple for a pharma company, 30x imo is conservative, so in the end $8 isn't that unrealistic.
Also anticipating a fair amount of dilution to come to fund the marketing campaign but there's clearly so much fat here that it won't matter in the end.
- Forums
- ASX - By Stock
- BOT
- Ann: Webinar Updated Commercial Research for Sofpironium Bromide
Ann: Webinar Updated Commercial Research for Sofpironium Bromide, page-17
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $710.3K | 1.907M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 326642 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 15257 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 374142 | 0.370 |
10 | 284708 | 0.365 |
9 | 252187 | 0.360 |
8 | 167011 | 0.355 |
8 | 518350 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 1059380 | 19 |
0.385 | 237102 | 7 |
0.390 | 375062 | 22 |
0.395 | 378120 | 10 |
0.400 | 876366 | 23 |
Last trade - 13.08pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online